食管癌術(shù)后應(yīng)用艾迪注射液對(duì)血漿sCD44s影響的臨床研究.pdf

1、南京中醫(yī)藥大學(xué)碩士學(xué)位論文食管癌術(shù)后應(yīng)用艾迪注射液對(duì)血漿sCD44s影響的臨床研究姓名：林娜申請(qǐng)學(xué)位級(jí)別：碩士專業(yè)：中醫(yī)外科學(xué)指導(dǎo)教師：潘立群20050501南京中醫(yī)藥大學(xué)碩士學(xué)位論文ObjectiveAgreatdealresearchshow，forthemoment，transferandrecurafteroperationarestillmainreasonsfortumorsufferer’Sdeath，Occurrence

2、anddevelopmentoftumoristied—upcloselywithsystemimmunoreactionRedbloodcellimmunity(RCI)isoneimportantpartofimmunity，improvingRCIfunctioncanrestraintumortotransferTheobjectiveofthisresearchistostudytheinfluenceofaidiinject

3、iononRCIandtumortransferinmoleculelevel，bymeasuringplasmasCD44s，investigatingitsfunctiononesophagealcarcinomapatientsafteroperationearly，deepentheresearch，offertheoryproofforapplyresisttumorChinesetraditionalmedicineduri

4、ngall—aroundoperation。toestablishciinicstudybaseforexplorenewgenerationofresisttumorChinesetraditionalmedicineMethodWetotallygot9patients，applyearlyaidiinjectionafteroperationonexperimentalgroup，controlgroupnotyetMeasure

5、plasmasCD44sthroughELISA，eualuateaidiinjectionfunctiononimmunity1esultThepre—treatmentbloodplasmasC044slevelthecontrolgroupbloodplasmasCD44slevelisxs=24980667lng／m1theexperimentationgroupbloodplasmasCD44slevelisxs=239257

6、220ng／ml，byttest，仁041005，thereisnosignificantdifferenceinstatisticsbetweenthetwogroupsAftertreatmentbloodplasmasCD44sleveltheexperimentationgroupbloodplasmasCD44slevelisxs=159677457ng／m1thecontrolgroupbloodplasmasCD44sle